First Republic Investment Management Inc. decreased its stake in Express Scripts Holding Company (NASDAQ:ESRX) by 19.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 38,586 shares of the company’s stock after selling 9,230 shares during the period. First Republic Investment Management Inc.’s holdings in Express Scripts were worth $2,443,000 at the end of the most recent reporting period.
Several other institutional investors also recently made changes to their positions in the company. Burt Wealth Advisors boosted its stake in Express Scripts by 11.4% during the second quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock worth $108,000 after buying an additional 174 shares in the last quarter. CKW Financial Group boosted its stake in Express Scripts by 20.0% during the second quarter. CKW Financial Group now owns 1,800 shares of the company’s stock worth $115,000 after buying an additional 300 shares in the last quarter. First Personal Financial Services boosted its stake in Express Scripts by 199.1% during the second quarter. First Personal Financial Services now owns 2,103 shares of the company’s stock worth $134,000 after buying an additional 1,400 shares in the last quarter. Financial Management Professionals Inc. boosted its stake in Express Scripts by 140.1% during the second quarter. Financial Management Professionals Inc. now owns 2,334 shares of the company’s stock worth $149,000 after buying an additional 1,362 shares in the last quarter. Finally, Monroe Bank & Trust MI boosted its stake in Express Scripts by 74.8% during the third quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock worth $156,000 after buying an additional 970 shares in the last quarter. Institutional investors and hedge funds own 88.44% of the company’s stock.
Express Scripts Holding Company (ESRX) opened at $68.39 on Tuesday. The company has a quick ratio of 0.61, a current ratio of 0.73 and a debt-to-equity ratio of 0.86. Express Scripts Holding Company has a twelve month low of $55.80 and a twelve month high of $73.52. The stock has a market capitalization of $38,598.32, a PE ratio of 9.96, a P/E/G ratio of 1.01 and a beta of 0.88.
Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 EPS for the quarter, hitting the Zacks’ consensus estimate of $1.90. The firm had revenue of $24.68 billion during the quarter, compared to analyst estimates of $25.68 billion. Express Scripts had a return on equity of 25.46% and a net margin of 3.64%. The company’s revenue was down 2.9% on a year-over-year basis. During the same period last year, the company earned $1.74 earnings per share. research analysts predict that Express Scripts Holding Company will post 7.01 EPS for the current fiscal year.
ESRX has been the topic of a number of recent research reports. ValuEngine downgraded shares of Express Scripts from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Robert W. Baird reissued a “hold” rating and set a $56.00 price objective on shares of Express Scripts in a report on Friday, September 1st. Jefferies Group set a $72.00 price objective on Express Scripts and gave the company a “buy” rating in a report on Tuesday, August 29th. Raymond James Financial reissued an “underperform” rating on shares of Express Scripts in a report on Monday, October 9th. Finally, Zacks Investment Research cut Express Scripts from a “buy” rating to a “sell” rating in a report on Tuesday, October 24th. Six research analysts have rated the stock with a sell rating, eleven have issued a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. Express Scripts has an average rating of “Hold” and an average target price of $70.67.
In related news, VP Phyllis S. Anderson sold 643 shares of Express Scripts stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $62.37, for a total value of $40,103.91. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Timothy C. Wentworth acquired 8,000 shares of the stock in a transaction that occurred on Tuesday, October 31st. The stock was purchased at an average price of $61.13 per share, with a total value of $489,040.00. Following the completion of the transaction, the chief executive officer now owns 98,628 shares of the company’s stock, valued at $6,029,129.64. The disclosure for this purchase can be found here. 0.68% of the stock is owned by company insiders.
COPYRIGHT VIOLATION WARNING: “First Republic Investment Management Inc. Has $2.44 Million Holdings in Express Scripts Holding Company (ESRX)” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright and trademark laws. The legal version of this news story can be read at https://www.dispatchtribunal.com/2017/12/12/first-republic-investment-management-inc-has-2-44-million-holdings-in-express-scripts-holding-company-esrx.html.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.